Market Overview:
The global on-body injectors market is expected to grow at a CAGR of 10.8% during the forecast period from 2018 to 2030. The growth of this market can be attributed to the increasing prevalence of chronic diseases, technological advancements in on-body injectors, and rising demand for minimally invasive procedures. Based on type, the global on-body injectors market is segmented into electronic injectors, mechanical injectors, and others. The electronic injector segment is expected to grow at a higher CAGR during the forecast period as compared to other segments due to its advantages such as accuracy and precision in dosing drugs. Based on application, the global on-body injectors market is segmented into immuno-oncology, diabetes mellitus (DM), cardiovascular diseases (CVDs), and others. The immuno-oncology application segment is expected to grow at a higher CAGR during the forecast period owing to increasing incidence of cancer across the globe.
Product Definition:
On-body injectors are a type of medical device that is used to inject a patient with medication. On-body injectors are important because they allow patients to self-administer medication without having to go to the doctor or hospital.
Electronical Injectors:
Electronic injectors are devices used to deliver drugs subcutaneously. They comprise of a battery-powered or electric motor, which is used to push the drug under the skin in a controlled manner. The most common type of electronic injector is an autoinjector, also known as manual injection device or portable injection device.
Mechanical Injectors:
Mechanical injectors are devices that automate the process of drug delivery from a vial to an injection site. They can be used for multiple types of injections including, butadiene-based implants, cemented and noncemented surgical implants as well as semi-solid and liquid formulations. Mechanical injectors have gained popularity in recent years due to their cost effectiveness compared to syringes and vials.
Application Insights:
The others segment held the largest share of the global on-body injectors market in 2017. This segment includes oncology, endocrinology, infectious diseases and other applications. The growing demand for immunization against a wide range of infectious diseases is expected to be one of the key factors driving this application segment over the forecast period.
Oncology was observed as one of the fastest-growing segments owing to increasing R&D initiatives by various companies for developing new drugs and vaccines for cancer treatment. For instance, in January 2018 Pfizer Inc., a U.S.-based pharmaceutical company announced about entering into an agreement with Anshui Pharmaceutical Co., Ltd.; China based biopharmaceutical company under which it will receive Chinese FDA approval and commercialize its investigational vaccine Cervarix globally within five years if approved by Chinese FDA during that time frame.
Regional Analysis:
North America dominated the global on-body injectors market in 2017. This can be attributed to various factors such as favorable reimbursement policies, high healthcare expenditure and awareness regarding these devices. Asia Pacific is expected to grow at a lucrative rate over the forecast period owing to increasing government initiatives for improving public health system, rising disposable income of consumers and rapid urbanization & industrialization.
Major players operating in this industry include Becton; Dickinson and Company; Johnson & Johnson Services Inc.; Merck Group; Pfizer Inc.; sanofi Aventis; Novo Nordisk A/S; Unilife Corporation (UPS); J&J Snack Foods Corp.
Growth Factors:
- Increasing prevalence of chronic diseases: The global prevalence of chronic diseases is increasing at an alarming rate. This is primarily because of the changing lifestyles and dietary habits of people across the world. On-body injectors can help in delivering drugs directly to the site of action, which helps in reducing the dosage required and also minimizes the side effects associated with traditional drug delivery methods.
- Growing demand for personalized medicine: There is a growing demand for personalized medicines across the world as patients are increasingly becoming aware about their health conditions and want treatments that are specific to them. On-body injectors can play an important role in delivering personalized medicines directly to the target site, thus helping in achieving better therapeutic outcomes.
- Technological advancements: The on-body injector market is witnessing rapid technological advancements, with new products being launched at a faster pace than ever before. This has led to increased competition among players and has resulted in significant cost reductions for on-body injector devices over time. Moreover, continuous innovation is likely to result in even more advanced devices being launched into this market over time, thereby driving its growth further still..
Scope Of The Report
Report Attributes
Report Details
Report Title
On-body Injectors Market Research Report
By Type
Electronical Injectors, Mechanical Injectors, Others
By Application
Immuno-oncology, Diabetes, Cardiovascular Diseases, Others
By Companies
BD Medical, Medtronic, Insulet, Sensile Medical, Ypsomed, Enable Injections, Roche, ScPharmaceuticals, SteadyMed, CeQur, Tandem Diabetes Care, Valeritas, SteadyMed Therapeutics, Amgen
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
174
Number of Tables & Figures
122
Customization Available
Yes, the report can be customized as per your need.
Global On-body Injectors Market Report Segments:
The global On-body Injectors market is segmented on the basis of:
Types
Electronical Injectors, Mechanical Injectors, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Immuno-oncology, Diabetes, Cardiovascular Diseases, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- BD Medical
- Medtronic
- Insulet
- Sensile Medical
- Ypsomed
- Enable Injections
- Roche
- ScPharmaceuticals
- SteadyMed
- CeQur
- Tandem Diabetes Care
- Valeritas
- SteadyMed Therapeutics
- Amgen
Highlights of The On-body Injectors Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Electronical Injectors
- Mechanical Injectors
- Others
- By Application:
- Immuno-oncology
- Diabetes
- Cardiovascular Diseases
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the On-body Injectors Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
On-body injectors are a type of medical device that is inserted under the skin on the body to deliver medication. They are often used to treat conditions such as diabetes, high blood pressure, and heart disease.
Some of the major companies in the on-body injectors market are BD Medical, Medtronic, Insulet, Sensile Medical, Ypsomed, Enable Injections, Roche, ScPharmaceuticals, SteadyMed, CeQur, Tandem Diabetes Care, Valeritas, SteadyMed Therapeutics, Amgen.
The on-body injectors market is expected to register a CAGR of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 On-body Injectors Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 On-body Injectors Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 On-body Injectors Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the On-body Injectors Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global On-body Injectors Market Size & Forecast, 2018-2028
4.5.1 On-body Injectors Market Size and Y-o-Y Growth
4.5.2 On-body Injectors Market Absolute $ Opportunity
Chapter 5 Global On-body Injectors Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 On-body Injectors Market Size Forecast by Type
5.2.1 Electronical Injectors
5.2.2 Mechanical Injectors
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global On-body Injectors Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 On-body Injectors Market Size Forecast by Applications
6.2.1 Immuno-oncology
6.2.2 Diabetes
6.2.3 Cardiovascular Diseases
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global On-body Injectors Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 On-body Injectors Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America On-body Injectors Analysis and Forecast
9.1 Introduction
9.2 North America On-body Injectors Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America On-body Injectors Market Size Forecast by Type
9.6.1 Electronical Injectors
9.6.2 Mechanical Injectors
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America On-body Injectors Market Size Forecast by Applications
9.10.1 Immuno-oncology
9.10.2 Diabetes
9.10.3 Cardiovascular Diseases
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe On-body Injectors Analysis and Forecast
10.1 Introduction
10.2 Europe On-body Injectors Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe On-body Injectors Market Size Forecast by Type
10.6.1 Electronical Injectors
10.6.2 Mechanical Injectors
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe On-body Injectors Market Size Forecast by Applications
10.10.1 Immuno-oncology
10.10.2 Diabetes
10.10.3 Cardiovascular Diseases
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific On-body Injectors Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific On-body Injectors Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific On-body Injectors Market Size Forecast by Type
11.6.1 Electronical Injectors
11.6.2 Mechanical Injectors
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific On-body Injectors Market Size Forecast by Applications
11.10.1 Immuno-oncology
11.10.2 Diabetes
11.10.3 Cardiovascular Diseases
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America On-body Injectors Analysis and Forecast
12.1 Introduction
12.2 Latin America On-body Injectors Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America On-body Injectors Market Size Forecast by Type
12.6.1 Electronical Injectors
12.6.2 Mechanical Injectors
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America On-body Injectors Market Size Forecast by Applications
12.10.1 Immuno-oncology
12.10.2 Diabetes
12.10.3 Cardiovascular Diseases
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) On-body Injectors Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) On-body Injectors Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) On-body Injectors Market Size Forecast by Type
13.6.1 Electronical Injectors
13.6.2 Mechanical Injectors
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) On-body Injectors Market Size Forecast by Applications
13.10.1 Immuno-oncology
13.10.2 Diabetes
13.10.3 Cardiovascular Diseases
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 On-body Injectors Market: Competitive Dashboard
14.2 Global On-body Injectors Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 BD Medical
14.3.2 Medtronic
14.3.3 Insulet
14.3.4 Sensile Medical
14.3.5 Ypsomed
14.3.6 Enable Injections
14.3.7 Roche
14.3.8 ScPharmaceuticals
14.3.9 SteadyMed
14.3.10 CeQur
14.3.11 Tandem Diabetes Care
14.3.12 Valeritas
14.3.13 SteadyMed Therapeutics
14.3.14 Amgen
